Learn More
Medchemexpress LLC Elacestrant dihydrochloride | 1349723-93-8 | 99.5% | 531.56 | 50 MG

Supplier: Medchemexpress LLC HY19822A50MG
Elacestrant dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) that can inhibit the growth of ER+ breast cancer cell lines in vitro and in vivo. It is effective against ERα and ERβ, making it suitable for research into hormone receptor-positive breast cancers.
- Orally available and selective estrogen receptor degrader (SERD)
- Inhibits the growth of ER+ breast cancer cell lines in vitro and in vivo
- Effective against ERα and ERβ targets
- Suitable for various research applications in breast cancer studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.